DYN FY 2019 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$271,000

Operating Income

-$14M

Net Income

-$14M

EPS (Diluted)

$-0.30

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$26,000

Balance Sheet

Total Assets

$16M

Total Liabilities

$2M

Stockholders' Equity

$14M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$271,000	-$24,000	-1029.2%
Operating Income	-$14M	-$5M	-188.3%
Net Income	-$14M	-$5M	-181.4%